Shaping the global innovation and access landscape for better paediatric medicines: Global accelerator for paediatric formulations 2022–2024 strategy

Overview

The lack of appropriate paediatric medicines and formulations is hindering the achievement of the Sustainable Development Goals and universal health coverage and is putting children’s lives at risk.

The Global Accelerator for Paediatric Formulations Strategy (GAP-f) 2022–2024 strategy builds from the work undertaken to date by the network of leading partners, both individually and collectively, through GAP-f. With this new strategy, we are excited to increase our footprint into a broader set of diseases to bring us closer to our vision of all children having equitable access to the medicines they need.